EUCTR2015-001042-28-Outside-EU/EEA进行中（未招募）不适用
Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children with ADHD (The ABC Study)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 89
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- ADHD diagnosis of all subtypes (except Not Otherwise Specified)
- •- Patients with total or subscale Attention Deficit Hyperactivity Disorder Rating Scale (ADHD RS-IV) scores > =90th percentile relative to the general population of children by age and gender
- •- Patients currently receiving ADHD medication must be inadequately managed on their current stimulant dose and meet this criteria at the screening visit
- •- Ability to read and understand English
- •- Ability to attend school regularly
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 89
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Estimated Full Scale IQ score of 80 or below, Severe Learning Disability
- •- History of or current, primary diagnosis of: severe anxiety disorder, conduct disorder, psychotic disorders, Pervasive Developmental Disorder, Eating Disorder, Obsessive-Compulsive Disorder, Sleep Disorder, Major Depressive Disorder, Bipolar Disorder, Substance Use Disorder, Chronic Tic Disorder, personal or family history of Tourette's Syndrome
- •- Weight < 3rd percentile for age
- •- History of hospitalization for treatment of a mood, anxiety, or psychotic disorder
- •- History of failed response to methylphenidate
研究者
相似试验
已完成
不适用
Randomised, Double-Blind, Placebo Controlled, Cross Over Trial of a Parenteral Modified Cobratoxin in AdrenomyeloneuropathyISRCTN48334111ReceptoPharm Inc. (USA)
已完成
不适用
Double-Blind, Randomized, Placebo-Controlled, Mono-Centre Pilot (Proof-of-Concept) Study to Investigate the Effect of IMPP-1 on Immune Functions That Contribute to Resistance to (Respiratory) Infection in Healthy SubjectsHealthy SubjectsDRKS00010568Chief Executive Officer, NutriLeads B.V.60
进行中（未招募）
1 期
A Study to Investigate the Efficacy and Safety of the study drug, GLPG0634, in Subjects With Active Crohn’s Disease With Evidence of Mucosal UlceratioCrohn’s Disease With Evidence of Mucosal UlcerationMedDRA version: 17.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2013-002857-32-GBGalapagos NV180
进行中（未招募）
不适用
A Study to Investigate the Efficacy and Safety of the study drug, GLPG0634, in Subjects With Active Crohn’s Disease With Evidence of Mucosal UlceratioCrohn’s Disease With Evidence of Mucosal UlcerationMedDRA version: 17.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2013-002857-32-HUGalapagos NV180
进行中（未招募）
不适用
A Study to Investigate the Efficacy and Safety of the study drug, GLPG0634, in Subjects With Active Crohn’s Disease With Evidence of Mucosal UlceratioCrohn’s Disease With Evidence of Mucosal UlcerationMedDRA version: 17.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2013-002857-32-BEGalapagos NV180